Molecule Updates

Affinivax is advancing a next generation vaccine technology platform to enable the development of vaccines that provide the highest level of protection against challenging…

Cullinan Oncology develops high value therapeutics geared towards dramatically improving the standard of care for those living with cancer. The Wistar Institute is an international…

Cytonus Therapeutics Inc. is a spinout biotechnology company based on work done by founder and CSO Richard Klemke, Ph.D., professor of pathology at University of California San…

SanBio Company Limited develops, produces, and sells regenerative cell medicines for central nervous system. It added a program for treatment of chronic motor deficit from cerebral…

Navitor Pharmaceuticals, is a biopharmaceutical company developing novel medicines by targeting mTORC cellular nutrient signalling pathway. It initiated Part B of its Phase 1…

eFFECTOR Therapeutics is a clinical-stage biopharmaceutical company focused on pioneering the discovery and development of a new class of oncology drugs known as selective…

Forbius, developing biologics for the treatment of cancer and fibrosis, announced today that the first patient was dosed in a Phase 1 clinical trial with AVID200. AVID200…